News Biogen takes on Tecfidera adherence issues Company hopes to coach patients with stomach side-effects.
News Celgene baffles market with Crohn's drug data Analysts left guessing from snippet of early phase data.
News Shire buys rights to Pfizer gastrointestinal drug Shire has bought rights to PF-00547659 for an undisclosed sum.
News Biosimilar switching not suitable for all patients Antibodies against originator will also target biosimilar.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
